Procter & Gamble Health Share Price
Small Cap | Pharmaceuticals and health care | NSE: PGHL | BSE: 500126
₹5,294.95 
-28.45 (-0.53 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 5,360.00
High (₹) 5,360.00
Low (₹) 5,225.00
Prev. Close (₹) 5,323.40
Volume 255
VWAP (₹) 5,320.90
ROCE (%) 51.13
Industry P/E 44.81
TTM P/E 37.15
P/B Ratio 16.27
Market Cap (₹) Cr.8,757.17
Dividend Yield (%)4.91
EPS (₹) 121.00
ROE37.32%
Sales Growth (%) -6.37
Profit Growth (%)-12.42
Day Range
5,360.005,360.00
52 Week Range
4,640.305,835.95
Historical Returns
Returns (6M)
1.84 %
Returns (1Y)
4.17 %
Returns (3Y)
14.68 %
Returns (5Y)
29.46 %
Returns (6M)
1.84 %
Returns (1Y)
4.17 %
Returns (3Y)
14.68 %
Returns (5Y)
29.46 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 39.95
MFI 66.85
ATR 171.46
Commodity Channel Index 22.25
ROC125 1.70
ROC21 -3.22
Williams %R -66.03
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 5,392.84 | 5,462.27 | 5,528.54 | 5,326.57 | 5,257.14 | 5,190.87 | 5,121.44 |
| Week Ago | 5,370.86 | 5,438.63 | 5,479.06 | 5,330.43 | 5,262.66 | 5,222.23 | 5,154.46 |
| Month Ago | 5,543.39 | 5,594.97 | 5,678.94 | 5,459.42 | 5,407.84 | 5,323.87 | 5,272.29 |
EMA & SMA
5294.95
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
16
5 Day 5269.71
9 Day 5308.45
10 Day 5340.80
12 Day 5321.37
14 Day 5303.82
20 Day 5308.90
26 Day 5349.47
50 Day 5362.47
100 Day 5325.47
200 Day 5196.62
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 31 Jan, 2025 | Rs.80.0000 per share(800%)Interim Dividend | 21 Feb, 2025 | 21 Feb, 2025 |
| 22 Aug, 2024 | Rs.60.0000 per share(600%)Final Dividend | 28 Nov, 2024 | 01 Jan, 1970 |
| 26 Jan, 2024 | Rs.150.0000 per share(1500%)Special Dividend | 14 Feb, 2024 | 14 Feb, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 18 Feb, 2025 | NSE India | Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, we are submitting herewith the Integrated Filing (Financial) for the quarter and six months ended December 31, 2024 |
| 18 Feb, 2025 | BSE India | Dear Sir,\r\n\r\nPursuant to SEBI circular dated December 31, 2024, we are hereby submitting integrated financial filing for the quarter and half year ended December 31, 2024. \r\n\r\nRequest you to kindly take note of the same. |
| 17 Feb, 2025 | NSE India | Unaudited Financial Results for the quarter ended December 31, 2024 and Interim Dividend for Financial Year 2024-25 |
| 13 Feb, 2025 | NSE India | Procter & Gamble Health Limited has informed the Exchange regarding ''Communication on TDS on dividend income declared by the Company''. |
| 13 Feb, 2025 | BSE India | Find enclosed the communication with respect to tax deduction at source on dividend income declared by the Company |
| 12 Feb, 2025 | NSE India | PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 12 Feb, 2025 | NSE India | PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 12-Feb-2025 for Dividend |
| 12 Feb, 2025 | BSE India | Find enclosed press release on the unaudited financial results for the quarter ended December 31,2024. |
| 12 Feb, 2025 | BSE India | Find enclosed communication with respect to appointment of chairperson of the Board. |
| 12 Feb, 2025 | BSE India | Find enclosed communication with respect to change in directorate-retirement |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Interim Dividend | -- | 01 Feb, 2025 | 12 Feb, 2025 |
| Quarterly Results | -- | 01 Oct, 2024 | 04 Nov, 2024 |
| Audited Results & Final Dividend | -- | 01 Jul, 2024 | 21 Aug, 2024 |
| Quarterly Results | -- | 01 Apr, 2024 | 02 May, 2024 |
| Quarterly Results & Interim Dividend | -- | 15 Jan, 2024 | 06 Feb, 2024 |
| Quarterly Results | -- | 28 Sept, 2023 | 03 Nov, 2023 |
| Audited Results & Final Dividend | -- | 18 Jul, 2023 | 23 Aug, 2023 |
| Quarterly Results | -- | 25 Apr, 2023 | 15 May, 2023 |
| Quarterly Results & Interim Dividend | -- | 18 Jan, 2023 | 08 Feb, 2023 |
| Quarterly Results & Interim Dividend | -- | 17 Jan, 2023 | 05 Feb, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Procter & Gamble Health
Procter & Gamble Health is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1151.26 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2024. Read More
Parent Organisation
MNC Associate
Founded
1967
Managing Director
Mr. Milind Thatte
NSE Symbol
PGHL
Procter & Gamble Health Management
| Name | Designation |
|---|---|
| Mr. Suresh Talwar | Chairman & Ind.Director |
| Mr. Milind Thatte | Managing Director |
| Mr. Lokesh Chandak | Executive Director & CFO |
| Ms. Seema Sambasivan | Non Executive Director |
| Mr. Aalok Agrawal | Non Executive Director |
| Mrs. Rani Jadhav | Independent Director |
| Mr. S Madhavan | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Procter & Gamble Health
What is the share price of Procter & Gamble Health?
The share price of Procter & Gamble Health on 21 Feb, 2025 is ₹ 5,294.95.
What is 52W high and 52W low share price of Procter & Gamble Health?
The highest and lowest 52W share prices of Procter & Gamble Health are ₹ 5835.950 and ₹ 4640.300
What is the market cap of Procter & Gamble Health?
The market capitalization of Procter & Gamble Health as of 21 Feb, 2025 is ₹ 8,757.17 Crores
What is the P/E ratio of Procter & Gamble Health?
The current P/E ratio of Procter & Gamble Health as of 21 Feb, 2025 is 44.81
What is the PB ratio of Procter & Gamble Health?
The PB ratio of Procter & Gamble Health as of 21 Feb, 2025 is 16.27
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)